Green Planet Bioengineering Co., Ltd.

What they do

Green Planet operates as a public reorganized shell corporation with the sole purpose of acquiring or merging with an existing business. The company has no active business operations and generates no operating revenues. Historically, it was involved in the agritech sector in China through a subsidiary, Elevated Throne, which was divested in 2010.

Revenue drivers

• No operating segments — The company has no active business operations and no revenue-generating activities.
• Future acquisition target — Potential revenue would come only from a future business combination, which has not been identified.

Recent performance

For the years ended December 31, 2025 and 2024, the company reported no operating revenues. Total expenses were $35,842 in 2025 and $35,544 in 2024, primarily for accounting and compliance costs. Net income was negative in all reported years, including a loss of $35,842 in 2025. Cash flow from operations was negative $36,544 in 2025. As of June 30, 2026, shareholder equity was negative $517,825 and cash and equivalents were $0.

Strategy

The company's stated strategy is to identify and execute a merger or acquisition with an existing business. To do so, it must secure adequate financing from future investors or find profitable opportunities. It also needs continued financial support from Global Funds, its majority stockholder, to pay public company expenses. Management acknowledges that if opportunities are not identified soon, business plans will be delayed.

Risks

• Going concern risk — The company's ability to continue as a going concern depends on continued support from its majority stockholder, Global Funds, and there is substantial doubt about its viability.
• No revenue or operations — The company has no active business and no operating revenues, making it entirely reliant on finding a merger or acquisition target.
• Funding dependency — The company cannot fund its expenses without related-party support and future investor financing may not be available.
• Compliance costs — As a public company, it incurs significant legal and accounting expenses under the Exchange Act, which strain limited resources.

Outlook

Management states that the company will continue to seek funding and business opportunities, but these depend on prevailing market conditions. If no opportunities are found in the near term, the company will experience delays in effecting its business plans. The outlook is uncertain, with no timeline or specific targets disclosed.